Cancer relapse and metastasis are responsible for the vast majority of cancer-related fatalities, often because traditional imaging tools like CT and MRI scans fail to catch the disease's return in time. This video highlights a groundbreaking and highly affordable blood test—India's first-in-class medical device approved by the Drug Controller General of India. Developed by Dr. Jayant Khandare, the OncoDiscover test requires only a small volume of blood to identify circulating tumor cells (CTCs) and detect minimal residual disease before it becomes uncontrollable. Clinically validated in partnership with Tata Memorial Hospital in Mumbai, this painless innovation provides oncologists with a powerful tool to monitor patients, optimize treatment, and ensure families never have to hear the dreaded words, "It's too late."